Loading…
Qualification of a noninvasive magnetic resonance imaging biomarker to assess tumor oxygenation
Although hypoxia has been long recognized as a crucial factor impairing tumor response in many therapeutic schemes, atraumatic and reliable methods of individually quantifying tumor oxygenation are still lacking in day-to-day clinical practice. The aim of this work was to investigate the potentially...
Saved in:
Published in: | Clinical cancer research 2014-11, Vol.20 (21), p.5403-5411 |
---|---|
Main Authors: | , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-c309t-daf942139461847c1918d1f7838674c53d611a51a5a27ceee30161d16b1ac8d13 |
---|---|
cites | cdi_FETCH-LOGICAL-c309t-daf942139461847c1918d1f7838674c53d611a51a5a27ceee30161d16b1ac8d13 |
container_end_page | 5411 |
container_issue | 21 |
container_start_page | 5403 |
container_title | Clinical cancer research |
container_volume | 20 |
creator | Colliez, Florence Neveu, Marie-Aline Magat, Julie Cao Pham, Thanh Trang Gallez, Bernard Jordan, Bénédicte F |
description | Although hypoxia has been long recognized as a crucial factor impairing tumor response in many therapeutic schemes, atraumatic and reliable methods of individually quantifying tumor oxygenation are still lacking in day-to-day clinical practice. The aim of this work was to investigate the potentially quantitative properties of our recently described noninvasive magnetic resonance (MR) technique "MOBILE" (mapping of oxygen by imaging lipids relaxation enhancement) and to qualify this endogenous contrast as a tumor hypoxia marker.
The "MOBILE" technique, which assesses the longitudinal MR relaxation rate, R1, of lipid protons, was benchmarked with the parent technique which assesses the global (or water) R1, in response to a hyperoxic challenge (carbogen breathing) and to a hypoxic challenge (combretastatin A4) in MDA-MB-231 xenografts and in NT2 mammary tumors. Electron paramagnetic resonance (EPR) oximetry was used to quantitatively assess the tumor pO2 in matching tumors longitudinally.
Our study evidenced that (i) positive and negative changes in tumor oxygenation can be detected using MOBILE; (ii) a change in the R1 of lipids is positively correlated with a change in the tumor pO2 (P = 0.0217, r = 0.5097); (iii) measured lipid R1 values are positively correlated with absolute pO2 values in both tumor models (P = 0.0275, r = 0.3726); and (iv) changes in the R1 of lipids are more sensitive than changes in the global R1. As this technique presents unique translational properties, it seems promising for the individual longitudinal monitoring of tumor oxygenation in a clinical setting. |
doi_str_mv | 10.1158/1078-0432.CCR-13-3434 |
format | article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1619317635</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1619317635</sourcerecordid><originalsourceid>FETCH-LOGICAL-c309t-daf942139461847c1918d1f7838674c53d611a51a5a27ceee30161d16b1ac8d13</originalsourceid><addsrcrecordid>eNo9kN9LwzAQgIMobk7_BCWPvnTmmqRNH2X4Cwai6HPI0nRE22Qm7XD_vambwsEdx3d33IfQJZA5ABc3QEqREUbz-WLxmgHNKKPsCE2B8zKjecGPU_3HTNBZjB-EAAPCTtEk5zkRQsAUyZdBtbaxWvXWO-wbrLDzzrqtinZrcKfWzvRW42Cid8ppg23qWbfGK-s7FT5NwL3HKkYTI-6Hzgfsv3dr4343nqOTRrXRXBzyDL3f370tHrPl88PT4naZaUqqPqtVU7EcaMUKEKzUUIGooSkFFUXJNKd1AaB4CpWX2hhDCRRQQ7ECpRNJZ-h6v3cT_NdgYi87G7VpW-WMH6JMdEWhLChPKN-jOvgYg2nkJqSfwk4CkaNbOXqTozeZ3EqgcnSb5q4OJ4ZVZ-r_qT-Z9AeLHnXJ</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1619317635</pqid></control><display><type>article</type><title>Qualification of a noninvasive magnetic resonance imaging biomarker to assess tumor oxygenation</title><source>Freely Accessible Journals</source><creator>Colliez, Florence ; Neveu, Marie-Aline ; Magat, Julie ; Cao Pham, Thanh Trang ; Gallez, Bernard ; Jordan, Bénédicte F</creator><creatorcontrib>Colliez, Florence ; Neveu, Marie-Aline ; Magat, Julie ; Cao Pham, Thanh Trang ; Gallez, Bernard ; Jordan, Bénédicte F</creatorcontrib><description>Although hypoxia has been long recognized as a crucial factor impairing tumor response in many therapeutic schemes, atraumatic and reliable methods of individually quantifying tumor oxygenation are still lacking in day-to-day clinical practice. The aim of this work was to investigate the potentially quantitative properties of our recently described noninvasive magnetic resonance (MR) technique "MOBILE" (mapping of oxygen by imaging lipids relaxation enhancement) and to qualify this endogenous contrast as a tumor hypoxia marker.
The "MOBILE" technique, which assesses the longitudinal MR relaxation rate, R1, of lipid protons, was benchmarked with the parent technique which assesses the global (or water) R1, in response to a hyperoxic challenge (carbogen breathing) and to a hypoxic challenge (combretastatin A4) in MDA-MB-231 xenografts and in NT2 mammary tumors. Electron paramagnetic resonance (EPR) oximetry was used to quantitatively assess the tumor pO2 in matching tumors longitudinally.
Our study evidenced that (i) positive and negative changes in tumor oxygenation can be detected using MOBILE; (ii) a change in the R1 of lipids is positively correlated with a change in the tumor pO2 (P = 0.0217, r = 0.5097); (iii) measured lipid R1 values are positively correlated with absolute pO2 values in both tumor models (P = 0.0275, r = 0.3726); and (iv) changes in the R1 of lipids are more sensitive than changes in the global R1. As this technique presents unique translational properties, it seems promising for the individual longitudinal monitoring of tumor oxygenation in a clinical setting.</description><identifier>ISSN: 1078-0432</identifier><identifier>EISSN: 1557-3265</identifier><identifier>DOI: 10.1158/1078-0432.CCR-13-3434</identifier><identifier>PMID: 25208881</identifier><language>eng</language><publisher>United States</publisher><subject>Animals ; Biomarkers, Tumor - chemistry ; Biomarkers, Tumor - metabolism ; Cell Line, Tumor ; Female ; Humans ; Lipids - chemistry ; Magnetic Resonance Imaging - methods ; Mice ; Mice, Nude ; Neoplasms - metabolism ; Oxygen - metabolism</subject><ispartof>Clinical cancer research, 2014-11, Vol.20 (21), p.5403-5411</ispartof><rights>2014 American Association for Cancer Research.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c309t-daf942139461847c1918d1f7838674c53d611a51a5a27ceee30161d16b1ac8d13</citedby><cites>FETCH-LOGICAL-c309t-daf942139461847c1918d1f7838674c53d611a51a5a27ceee30161d16b1ac8d13</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/25208881$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Colliez, Florence</creatorcontrib><creatorcontrib>Neveu, Marie-Aline</creatorcontrib><creatorcontrib>Magat, Julie</creatorcontrib><creatorcontrib>Cao Pham, Thanh Trang</creatorcontrib><creatorcontrib>Gallez, Bernard</creatorcontrib><creatorcontrib>Jordan, Bénédicte F</creatorcontrib><title>Qualification of a noninvasive magnetic resonance imaging biomarker to assess tumor oxygenation</title><title>Clinical cancer research</title><addtitle>Clin Cancer Res</addtitle><description>Although hypoxia has been long recognized as a crucial factor impairing tumor response in many therapeutic schemes, atraumatic and reliable methods of individually quantifying tumor oxygenation are still lacking in day-to-day clinical practice. The aim of this work was to investigate the potentially quantitative properties of our recently described noninvasive magnetic resonance (MR) technique "MOBILE" (mapping of oxygen by imaging lipids relaxation enhancement) and to qualify this endogenous contrast as a tumor hypoxia marker.
The "MOBILE" technique, which assesses the longitudinal MR relaxation rate, R1, of lipid protons, was benchmarked with the parent technique which assesses the global (or water) R1, in response to a hyperoxic challenge (carbogen breathing) and to a hypoxic challenge (combretastatin A4) in MDA-MB-231 xenografts and in NT2 mammary tumors. Electron paramagnetic resonance (EPR) oximetry was used to quantitatively assess the tumor pO2 in matching tumors longitudinally.
Our study evidenced that (i) positive and negative changes in tumor oxygenation can be detected using MOBILE; (ii) a change in the R1 of lipids is positively correlated with a change in the tumor pO2 (P = 0.0217, r = 0.5097); (iii) measured lipid R1 values are positively correlated with absolute pO2 values in both tumor models (P = 0.0275, r = 0.3726); and (iv) changes in the R1 of lipids are more sensitive than changes in the global R1. As this technique presents unique translational properties, it seems promising for the individual longitudinal monitoring of tumor oxygenation in a clinical setting.</description><subject>Animals</subject><subject>Biomarkers, Tumor - chemistry</subject><subject>Biomarkers, Tumor - metabolism</subject><subject>Cell Line, Tumor</subject><subject>Female</subject><subject>Humans</subject><subject>Lipids - chemistry</subject><subject>Magnetic Resonance Imaging - methods</subject><subject>Mice</subject><subject>Mice, Nude</subject><subject>Neoplasms - metabolism</subject><subject>Oxygen - metabolism</subject><issn>1078-0432</issn><issn>1557-3265</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2014</creationdate><recordtype>article</recordtype><recordid>eNo9kN9LwzAQgIMobk7_BCWPvnTmmqRNH2X4Cwai6HPI0nRE22Qm7XD_vambwsEdx3d33IfQJZA5ABc3QEqREUbz-WLxmgHNKKPsCE2B8zKjecGPU_3HTNBZjB-EAAPCTtEk5zkRQsAUyZdBtbaxWvXWO-wbrLDzzrqtinZrcKfWzvRW42Cid8ppg23qWbfGK-s7FT5NwL3HKkYTI-6Hzgfsv3dr4343nqOTRrXRXBzyDL3f370tHrPl88PT4naZaUqqPqtVU7EcaMUKEKzUUIGooSkFFUXJNKd1AaB4CpWX2hhDCRRQQ7ECpRNJZ-h6v3cT_NdgYi87G7VpW-WMH6JMdEWhLChPKN-jOvgYg2nkJqSfwk4CkaNbOXqTozeZ3EqgcnSb5q4OJ4ZVZ-r_qT-Z9AeLHnXJ</recordid><startdate>20141101</startdate><enddate>20141101</enddate><creator>Colliez, Florence</creator><creator>Neveu, Marie-Aline</creator><creator>Magat, Julie</creator><creator>Cao Pham, Thanh Trang</creator><creator>Gallez, Bernard</creator><creator>Jordan, Bénédicte F</creator><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20141101</creationdate><title>Qualification of a noninvasive magnetic resonance imaging biomarker to assess tumor oxygenation</title><author>Colliez, Florence ; Neveu, Marie-Aline ; Magat, Julie ; Cao Pham, Thanh Trang ; Gallez, Bernard ; Jordan, Bénédicte F</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c309t-daf942139461847c1918d1f7838674c53d611a51a5a27ceee30161d16b1ac8d13</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2014</creationdate><topic>Animals</topic><topic>Biomarkers, Tumor - chemistry</topic><topic>Biomarkers, Tumor - metabolism</topic><topic>Cell Line, Tumor</topic><topic>Female</topic><topic>Humans</topic><topic>Lipids - chemistry</topic><topic>Magnetic Resonance Imaging - methods</topic><topic>Mice</topic><topic>Mice, Nude</topic><topic>Neoplasms - metabolism</topic><topic>Oxygen - metabolism</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Colliez, Florence</creatorcontrib><creatorcontrib>Neveu, Marie-Aline</creatorcontrib><creatorcontrib>Magat, Julie</creatorcontrib><creatorcontrib>Cao Pham, Thanh Trang</creatorcontrib><creatorcontrib>Gallez, Bernard</creatorcontrib><creatorcontrib>Jordan, Bénédicte F</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Clinical cancer research</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Colliez, Florence</au><au>Neveu, Marie-Aline</au><au>Magat, Julie</au><au>Cao Pham, Thanh Trang</au><au>Gallez, Bernard</au><au>Jordan, Bénédicte F</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Qualification of a noninvasive magnetic resonance imaging biomarker to assess tumor oxygenation</atitle><jtitle>Clinical cancer research</jtitle><addtitle>Clin Cancer Res</addtitle><date>2014-11-01</date><risdate>2014</risdate><volume>20</volume><issue>21</issue><spage>5403</spage><epage>5411</epage><pages>5403-5411</pages><issn>1078-0432</issn><eissn>1557-3265</eissn><abstract>Although hypoxia has been long recognized as a crucial factor impairing tumor response in many therapeutic schemes, atraumatic and reliable methods of individually quantifying tumor oxygenation are still lacking in day-to-day clinical practice. The aim of this work was to investigate the potentially quantitative properties of our recently described noninvasive magnetic resonance (MR) technique "MOBILE" (mapping of oxygen by imaging lipids relaxation enhancement) and to qualify this endogenous contrast as a tumor hypoxia marker.
The "MOBILE" technique, which assesses the longitudinal MR relaxation rate, R1, of lipid protons, was benchmarked with the parent technique which assesses the global (or water) R1, in response to a hyperoxic challenge (carbogen breathing) and to a hypoxic challenge (combretastatin A4) in MDA-MB-231 xenografts and in NT2 mammary tumors. Electron paramagnetic resonance (EPR) oximetry was used to quantitatively assess the tumor pO2 in matching tumors longitudinally.
Our study evidenced that (i) positive and negative changes in tumor oxygenation can be detected using MOBILE; (ii) a change in the R1 of lipids is positively correlated with a change in the tumor pO2 (P = 0.0217, r = 0.5097); (iii) measured lipid R1 values are positively correlated with absolute pO2 values in both tumor models (P = 0.0275, r = 0.3726); and (iv) changes in the R1 of lipids are more sensitive than changes in the global R1. As this technique presents unique translational properties, it seems promising for the individual longitudinal monitoring of tumor oxygenation in a clinical setting.</abstract><cop>United States</cop><pmid>25208881</pmid><doi>10.1158/1078-0432.CCR-13-3434</doi><tpages>9</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1078-0432 |
ispartof | Clinical cancer research, 2014-11, Vol.20 (21), p.5403-5411 |
issn | 1078-0432 1557-3265 |
language | eng |
recordid | cdi_proquest_miscellaneous_1619317635 |
source | Freely Accessible Journals |
subjects | Animals Biomarkers, Tumor - chemistry Biomarkers, Tumor - metabolism Cell Line, Tumor Female Humans Lipids - chemistry Magnetic Resonance Imaging - methods Mice Mice, Nude Neoplasms - metabolism Oxygen - metabolism |
title | Qualification of a noninvasive magnetic resonance imaging biomarker to assess tumor oxygenation |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-05T00%3A09%3A28IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Qualification%20of%20a%20noninvasive%20magnetic%20resonance%20imaging%20biomarker%20to%20assess%20tumor%20oxygenation&rft.jtitle=Clinical%20cancer%20research&rft.au=Colliez,%20Florence&rft.date=2014-11-01&rft.volume=20&rft.issue=21&rft.spage=5403&rft.epage=5411&rft.pages=5403-5411&rft.issn=1078-0432&rft.eissn=1557-3265&rft_id=info:doi/10.1158/1078-0432.CCR-13-3434&rft_dat=%3Cproquest_cross%3E1619317635%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c309t-daf942139461847c1918d1f7838674c53d611a51a5a27ceee30161d16b1ac8d13%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=1619317635&rft_id=info:pmid/25208881&rfr_iscdi=true |